Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Elanco Animal Health Incorporated
New York, NY – March 18, 2025
Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, is investigating potential claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or “the Company”) (NYSE:ELAN). The investigation concerns whether Elanco and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Background
Elanco Animal Health Incorporated is a global leader in animal health, dedicated to improving the health and productivity of animals and food-producing animals. The Company operates through two segments: Animal Health and Livestock Production. Elanco Animal Health Incorporated is headquartered in Greenfield, Indiana.
Investigation Details
The investigation concerns whether Elanco and certain of its executives and directors violated the securities laws and/or engaged in other unlawful business practices. Specifically, the investigation focuses on whether Elanco made false and/or misleading statements and/or failed to disclose: (1) the true nature and extent of certain quality issues with Elanco’s animal health products; (2) the impact of these quality issues on Elanco’s financial results; and (3) Elanco’s internal controls and procedures for ensuring the quality of its animal health products.
Implications for Elanco Shareholders
The investigation may have significant implications for Elanco shareholders. If it is determined that Elanco and its executives and/or directors engaged in securities fraud or other unlawful business practices, Elanco shareholders may be able to recover their losses. Investors who purchased Elanco securities prior to November 7, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ELAN.
Impact on the World
The potential implications of this investigation extend beyond Elanco shareholders. Elanco Animal Health Incorporated is a significant player in the animal health industry, and any revelations of quality issues or financial misrepresentations could have far-reaching consequences. The animal health industry is a critical sector, as it plays a vital role in food production and animal welfare. Any negative news regarding Elanco could impact consumer confidence in the industry as a whole, as well as the reputation and financial performance of other animal health companies.
Conclusion
The investigation into Elanco Animal Health Incorporated by Bronstein, Gewirtz & Grossman, LLC is ongoing. If you are an Elanco shareholder and believe that you may have a claim, or have information or protected whistleblower information, please visit bgandg.com/ELAN. The law firm encourages you to contact it for a free consultation.
Investors should carefully monitor the investigation into Elanco Animal Health Incorporated. The potential implications for Elanco shareholders and the animal health industry as a whole could be significant.
